| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $939.8M | +6.6% |
| Cost of Revenue | $326.1M | +0.3% |
| R&D Expense | $255.9M | +4.4% |
| SG&A Expense | $108.9M | -3.6% |
| Operating Income | $108.5M | +62.4% |
| Pre-tax Income | $141.8M | +45.0% |
| Income Tax | $19.3M | +10.3% |
| Net Income | $30.3M | -62.3% |
| EPS (Basic) | $2.50 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.22B | +75.1% |
| Accounts Receivable | $126.1M | -3.5% |
| Inventory | $87.4M | -9.1% |
| Current Assets | $1.48B | +54.9% |
| Total Assets | $2.04B | +41.6% |
| Current Liabilities | $188.8M | +7.7% |
| Total Liabilities | $1.27B | +77.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $206.4M | +51.8% |
| Capital Expenditures | $10.1M | +34.8% |
| Investing Cash Flow | -$24.7M | +4.9% |
| Financing Cash Flow | $346.4M | +1187.2% |
| Free Cash Flow | $196.3M | +52.8% |
| +53.4% |
| EPS (Diluted) | $2.29 | +49.7% |
| Stockholders' Equity |
| $726.5M |
| +5.5% |